N-Trifluoroacetyldoxorubicin

N-Trifluoroacetyldoxorubicin

26295-56-7

C₂₉H₂₈F₃NO₁₂

C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5= C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)NC(=O)C(F)(F)F)O

n-trifluoroacetyladriamycin ; n-trifluoroacetyldoxorubicin ; ad-41 ; (1s,3s)- α-2,3,6-trideoxy-3-(2,2,2-trifluoroacetamido)-3-glycoloyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl l-lyxo-hexopyranoside ; (8s-cis)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-10-[[2,3,6-trideoxy-3-[(trifluoroacetyl)amino]-α-l-lyxo-hexopyranosyl]oxy]-5,12-naphthacenedione ; nsc 283464 ; (8s,10s)-7,8,9,10-tetrahydro-8-(hydroxyacetyl)-1-methoxy-10-[[3-(trifluoroacetylamino)-2,3,6-trideoxy-α-l-lyxo-hexopyranosyl]oxy]-6,8,11-trihydroxy-5,12-naphthacenedione